ExoCoBio Company
.jpg)
ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.
Founded Date:
2017-01-01
Last Funding Type:
Series C
Headquarters:
Seoul, Seoul-t'ukpyolsi, South Korea
Investors Number:
16
Technology:
Regenerative Medicine
Employee Number:
11-50
Industry:
Longevity
Estimated Revenue:
$1M to $10M
Last Funding Date:
2020-08-25
Funding Status:
Late Stage Venture
Investor Type:
For Profit
Total Funding:
$47 000 000